The troubled drugmaker takes another plunge as it reduces guidance. Here’s a quick survey of the firms that are taking a bath and those that look like geniuses.
ValueAct Capital’s Jeff Ubben is turning up the heat on Moody’s. Ubben disclosed in a regulatory filing Wednesday, after the stock market closed, that he has raised his stake in the debt rating agency’s common stock to 6.1 percent.
